Atypical hemolytic uremic syndrome associated with a factor B genetic variant and fluid-phase complement activation: an exception to the rule?

Marina Noris; Giuseppe Remuzzi

doi:10.1016/j.kint.2020.06.026

Related publications

Article2008

The Complement Factor H R1210C Mutation Is Associated With Atypical Hemolytic Uremic Syndrome

Rubén Martínez-Barricarte, Gaia Pianetti, Ruxandra Gautard, Joachim Misselwitz, Lisa Strain, Véronique Frémeaux‐Bacchi, Christine Skerka, Peter F. Zipfel, Tim Goodship, Marina Noris, Giuseppe Remuzzi, Santiago Rodrı́guez de Córdoba

Article2009

Atypical Hemolytic Uremic Syndrome Associated With Complement Factor H Autoantibodies and CFHR1/CFHR3 Deficiency

Beom Hee Lee, Soo Heon Kwak, Jae Il Shin, So Hee Lee, Hyun Jin Choi, Hee Gyung Kang, Il Soo Ha, Jae Seung Lee, Marie‐Agnès Dragon‐Durey, Yong Choi, Hae Il Cheong

Article2001

Complement factor H and hemolytic uremic syndrome

Peter F. Zipfel, Christine Skerka, Jessica Caprioli, Tamara Manuelian, Hartmut H.P. Neumann, Marina Noris, Giuseppe Remuzzi

Article2019

Complement Activation Contributes to the Pathophysiology of Shiga Toxin-Associated Hemolytic Uremic Syndrome

Simona Buelli, Carla Zoja, Giuseppe Remuzzi, Marina Morigi

Article2007

Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome

David Kavanagh, Anna Richards, Marina Noris, Richard E. Hauhart, M. Kathryn Liszewski, Diana Karpman, Judith A. Goodship, Véronique Frémeaux‐Bacchi, Giuseppe Remuzzi, Timothy H.J. Goodship, John Atkinson